Search
Zocainone
go.drugbank.com/drugs/DB21326ExperimentalZocainone has a monoisotopic molecular weight of 353.2 Da.
Atrimustine
go.drugbank.com/drugs/DB21376ExperimentalAtrimustine has a monoisotopic molecular weight of 719.28 Da.
Pirenperone
go.drugbank.com/drugs/DB21405ExperimentalPirenperone has a monoisotopic molecular weight of 393.19 Da.
Cinsebrutinib
go.drugbank.com/drugs/DB21640ExperimentalCinsebrutinib has a monoisotopic molecular weight of 383.2 Da.
Surzetoclax
go.drugbank.com/drugs/DB21698InvestigationalSurzetoclax has a monoisotopic molecular weight of 1038.41 Da.
Amcipatricin
go.drugbank.com/drugs/DB12333InvestigationalAmcipatricin has been used in trials studying the treatment of Cryptococcosis or Aspergillosis Infections. … Amcipatricin (as amcipatricin diascorbate; SPK-843) is a water-soluble partricin derivative patented by SPA Societa Prodotti Antibiotici S.p.A. and developed by Aparts and Kaken for the potential treatment
Chlorotoxin I-131
go.drugbank.com/drugs/DB05462InvestigationalThe synthetic version of this peptide has been manufactured and covalently linked to iodine 131 as a means of targeting radiation to tumor cells in the treatment of brain cancer.
Fleroxacin
go.drugbank.com/drugs/DB04576ExperimentalFleroxacin is a broad-spectrum antimicrobial fluoroquinolone. It strongly inhibits the DNA-supercoiling activity of DNA gyrase. Fleroxacin is not an inhibitor of CYP1A2.
Relebactam
go.drugbank.com/drugs/DB12377ApprovedInvestigational[label] It is considered to be a last-line treatment option and gained FDA approval as part of the combination product RecarbrioⓇ in July 2019.[L7568]
NADH
go.drugbank.com/drugs/DB00157ApprovedNutraceuticalIt is found widely in nature and is involved in numerous enzymatic reactions in which it serves as an electron carrier by being alternately oxidized (NAD+) and reduced (NADH).